Back to search

University of Ioannina

Ο ρόλος των CB1 υποδοχέων των κανναβινοειδών στις νευροβιολογικές δράσεις εξαρτησιογόνων φαρμάκων: Προεκτάσεις στη θεραπευτική

Abstract

dc:description

This study aimed to explore the behavioral and molecular effects of cannabinoids (Δ⁹-THC and WIN 55,212-2) in two phenotypes of rats which were distinguished on the basis of their vertical activity upon exposure to a novel environment as high responders (HR) and low responders (LR). The studied cannabinoids influenced motor activity in a biphasic, dose-dependent manner. Low doses stimulated motor activity under habituated conditions, whereas high doses suppressed motor activity in a unfamiliar environment. These responses were more pronounced in HR rats. The cannabinoid antagonist SR141716 reversed WIN 55,212-2-induced hyperactivity at high doses and hypoactivity at the higher doses as well, in both phenotypes. The regulation of DARPP-32 phosphorylation at Thr34 was affected in a dose-, phenotype- and region- dependent manner, following Δ⁹-THC and WIN 55,212-2 administration. Both doses of Δ⁹-THC increased DARPP-32 phosphorylation in most of the brain regions studied in both HR and LR rats, with the exception of the low dose that decreased DARPP-32 in the amygdala of LR rats. Also, a high dose of WIN 55,212-2 increased DARPP-32 phosporylation in certain brain regions in both the HR and the LR rats, whereas it decreased DARPP-32 phosphorylation in the prefrontal cortex of LR rats. Concerning the rewarding properties of cannabinoids our results showed that a low dose of WIN 55,212-2 administration did not produce CPP. However, WIN 55,212-2- exposed rats in CPP exhibited enhanced sensitivity to a challenge dose of d- amphetamine which administered upon completion of CPP procedure. WIN 55,212-2 did not modulate amphetamine-induced hyperactivity with the exception of a decrease in vertical activity induced following co-administration of WIN 55,212-2 at the higher dose. These modifications on d-amphetamine-induced motor activity were differentiated between the two phenotypes. Interestingly high doses of SR induced a decrease in motor activity induced by d-amphetamine. The administration of WIN 55,212-2 and SR did not affect place preference induced by cocaine. Further studies using higher doses of SR are needed. In conclusion, our results have shown that cannabinoids affect behavioural and neurobiological parameters in a specific way. It should be noticed that most of these alterations are more pronounced in HR rats. Most of the cannabinoids-induced effects are dependent on the drug used, the dose and the phenotype. This phenotypic differentiation provides important information on the mechanism of action of cannabinoids while essentially contributes to a better evaluation of the bimodal mode of action of cannabinoids.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chouliara, Olga
  • Χουλιάρα, Όλγα

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/17809

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chouliara, Olga; Χουλιάρα, Όλγα. Ο ρόλος των CB1 υποδοχέων των κανναβινοειδών στις νευροβιολογικές δράσεις εξαρτησιογόνων φαρμάκων: Προεκτάσεις στη θεραπευτική. University of Ioannina, 2009. http://hdl.handle.net/10442/hedi/17809